Generation of an enhancer-driven gene expression viral tool specific to dentate granule cell-types through direct hippocampal injection

Front Neurosci. 2024 Mar 14:18:1274174. doi: 10.3389/fnins.2024.1274174. eCollection 2024.

Abstract

Accurate investigations of neural circuitry require specific genetic access to individual circuit elements, i.e., the myriad neuronal cell-types in the brain. However, native promoters cannot achieve this because while most genes are expressed in the brain, few are expressed in a single neuronal cell-type. We recently used enhancers, the subcomponents of the transcriptional apparatus which tell promoters when and where to express, combined with heterologous minimal promoters to increase specificity of transgene expression, an approach we call Enhancer-Driven Gene Expression (EDGE). As we discuss, EDGE is a marked improvement in specificity over native promoters, but still requires careful anatomical analysis to avoid off-target effects. In this study we present a more complete set of genomic markers from the mouse brain and characterize a novel EDGE viral vector capable of specifically driving expression in distinct subtypes of hippocampal neurons, even though it can express in other cell-types elsewhere. The advent of cell-type specific viral tools in wild-type animals provides a powerful strategy for neural circuit investigation and holds promise for studies using animal models for which transgenic tools are not available.

Keywords: chromatin immunoprecipitation; dentate gyrus; genetic tool; rAAVs; stereotaxic injection.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This present study was supported by the FRIPRO ToppForsk grants Enhanced Transgenics (90096000) of the Research Council of Norway, the Kavli Foundation, the Centre of Excellence scheme of the Research Council of Norway Centre for Neural Computation (223262), the Egil and Pauline Braathen and Fred Kavli Centre for Cortical Microcircuits, and the National Infrastructure scheme of the Research Council of Norway NORBRAIN (97467) to CK, the Faculty of Medicine and Health Sciences NTNU contribution to the grant of the Research Council of Norway: Japan And Norway United in Brain, Education and Therapeutics JANUBET (274955) to CK and MW, a Research Council of Norway (RCN) FRIPRO grant to GQ (324305) and a grant from Trond Mohn Foundation (TMS2021TMT04) to CB. The Genomics Core Facility was funded by the Faculty of Medicine and Health Sciences at NTNU and the Central Norway Regional Health Authority.